Provision of SCID Screening Assay Kits
This is a contract result notice, not an open opportunity. Details from the official award data.
This sits in the lower-middle of the Health & Social Care band — a mid-scale opportunity. Based on 32,734 valued Health & Social Care tenders in our corpus.
A call off under National Microbiology Framework for the EONIS Q Assay methodology as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot (NBS) in-service evaluation for Severe Combined Immuno-Deficiency (SCID) in Screening laboratories to Revvity.
Make the case to bid
Reveal who to approach at NHS England, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- 7ee11c14-1da6-4e37-8db5-2c7b418c9f1d
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- CF-3132800D0O000000rwimUAA
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Health & Social Care
NHS England’s tender network